论文部分内容阅读
目的:探讨临床低钾性麻痹的诊断和治疗,为临床疾病的救护提供借鉴和参考。方法:本次研究选取我院门诊收治的低钾性麻痹患者65例,根据患者情况行静脉或口服补钾类药物进行治疗。对患者治疗前后血钾浓度进行检测和对比,说明治疗有效性。结果:治疗前日均发病次数为3.4次,均血钾浓度为2.7mmol/L;治疗后患者日均发病次数为0.5次,均血钾浓度为4.7mmol/L。对比统计值及P值发现,治疗后与治疗前:发病次数明显下降,差异具有显著性,P<0.01;血钾浓度出现明显上升,差异具有显著性,P<0.01。结论:针对低钾性麻痹患者采用及时补钾治疗能有效改善患者发病情况以及提升血钾浓度,避免病情进一步恶化,取得良好临床效果,值得广泛推广。
Objective: To investigate the clinical diagnosis and treatment of hypokalemic paralysis, provide reference and reference for the rescue of clinical diseases. Methods: In this study, 65 cases of hypokalemic paralysis treated in our hospital were selected and treated with intravenous or oral potassium-based drugs according to the patient’s condition. Before and after treatment of patients with serum potassium concentrations were detected and compared, indicating the effectiveness of treatment. Results: The average daily incidence of pre-treatment was 3.4 and the average serum potassium concentration was 2.7mmol / L. After treatment, the average daily incidence of patients was 0.5, with a mean serum potassium concentration of 4.7mmol / L. Compared with the statistical value and P value, the number of onset after treatment and before treatment: the incidence decreased significantly, the difference was significant (P <0.01); serum potassium concentration increased significantly, the difference was significant (P <0.01). Conclusions: The prompt potassium supplement treatment for patients with hypokalemic paralysis can effectively improve the incidence of patients and enhance the serum potassium concentration, to avoid further deterioration of the disease, and achieved good clinical results, it is worth widely disseminated.